Carmignac Gestion filings

This page lists the SEC filings reported by Carmignac Gestion.

SEC filings by Carmignac Gestion (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2023-02-13Carmignac GestionClearside Biomedical, Inc.2,400,3444.0%EDGAR
SC 13G/A2022-02-09Carmignac GestionClearside Biomedical, Inc.3,124,2525.2%EDGAR
SC 13G2021-02-12Carmignac GestionClearside Biomedical, Inc.3,540,9617.3%EDGAR
SC 13G/A2019-02-13Carmignac GestionGrubHub Inc.2,485,8162.7%EDGAR
SC 13G/A2019-02-13Carmignac GestionMERCADOLIBRE INC952,4522.1%EDGAR
SC 13G/A2018-02-06Carmignac GestionMERCADOLIBRE INC2,308,6645.2%EDGAR
SC 13G/A2018-02-06Carmignac GestionINTERCEPT PHARMACEUTICALS INC00.0%EDGAR
SC 13G2018-02-06Carmignac GestionGrubHub Inc.5,261,7166.1%EDGAR
SC 13G/A2017-02-07Carmignac GestionINTERCEPT PHARMACEUTICALS INC2,022,7928.2%EDGAR
SC 13G/A2017-02-07Carmignac GestionSantander Mexico Financial Group, S.A.B. de C.V.103,770,1353.2%EDGAR
SC 13G2017-02-07Carmignac GestionMERCADOLIBRE INC2,383,5235.4%EDGAR
SC 13G/A2016-02-09Carmignac GestionINTERCEPT PHARMACEUTICALS INC1,319,8875.4%EDGAR
SC 13G/A2016-02-09Carmignac GestionGroupon, Inc.00.0%EDGAR
SC 13G/A2016-02-09Carmignac GestionSantander Mexico Financial Group, S.A.B. de C.V.222,612,2906.7%EDGAR
SC 13G/A2015-02-09Carmignac GestionSantander Mexico Financial Group, S.A.B. de C.V.217,249,6706.5%EDGAR
SC 13G2015-02-09Carmignac GestionINTERCEPT PHARMACEUTICALS INC1,432,0716.7%EDGAR
SC 13G2015-02-09Carmignac GestionGroupon, Inc.47,255,0347.1%EDGAR
SC 13G2014-02-14Carmignac GestionSantander Mexico Financial Group, S.A.B. de C.V.179,996,2205.4%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.